Rierink
Member
Three new briefings are up in Rierink's "Research briefings" section. Each covers chemical identity, catalogue context and what the published literature reports. No protocols.
- Liraglutide: Chemical Identity and Catalog Context: https://rierink.com/en/blog/liraglutide-chemical-identity-and-catalog-context
- Pinealon Catalog Entry: The Single Defined Tripeptide Compound: https://rierink.com/en/blog/pinealon-catalog-entry-the-single-defined-tripeptide-compound
- Cagrilintide-Semaglutide Mixture: Open-Catalog Context and Metabolic Trial Evidence: https://rierink.com/en/blog/cagrili...en-catalog-context-and-metabolic-trial-eviden
All briefings: https://rierink.com/en/blog
Janoshik Testing Fund (vote on what gets tested next): https://rierink.com/en/blog/janoshik-testing-fund
Rierink, Porto, Portugal.
For laboratory research use only. Not for human or veterinary use.
- Liraglutide: Chemical Identity and Catalog Context: https://rierink.com/en/blog/liraglutide-chemical-identity-and-catalog-context
- Pinealon Catalog Entry: The Single Defined Tripeptide Compound: https://rierink.com/en/blog/pinealon-catalog-entry-the-single-defined-tripeptide-compound
- Cagrilintide-Semaglutide Mixture: Open-Catalog Context and Metabolic Trial Evidence: https://rierink.com/en/blog/cagrili...en-catalog-context-and-metabolic-trial-eviden
All briefings: https://rierink.com/en/blog
Janoshik Testing Fund (vote on what gets tested next): https://rierink.com/en/blog/janoshik-testing-fund
Rierink, Porto, Portugal.
For laboratory research use only. Not for human or veterinary use.